Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05306301
Title Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gruppo Italiano Malattie EMatologiche dell'Adulto
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.